N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients
By P. Bettencourt, A. Azevedo, J. Pimenta, F. Friões, S. Ferreira, A. Ferreira. Circulation, 2004
703 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/e126aa2538eee2e8376d01e263c9f879fa1e832f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- T. Horwich
- J. Januzzi
- Allan S. Jaffe
- C. Yancy
- M. Drazner
- Véronique L. Roger
- M. Gheorghiade
Citations in the corpus
- Biomarkers in acute cardiac disease: the present and the future. (2006, background): “There is prognostic value of BNP and NT-proBNP as well in patients with heart failure (84, 85 ).”
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “BNP and NT-proBNP levels improve with treatment of chronic HF (225,272–274), with lowering of levels over time in general, correlating with improved clinical outcomes (248,251,254,260).”
- Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. (2012, background): “NT-ProBNP is released from myocardial cells in response to increased wall stress, and levels increase with both asymptomatic and symptomatic left ventricular dysfunction, making it a useful tool in the diagnosis of cardiac failure and a strong prognostic factor in congestive heart failure.(16) Howev”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “BNP and NT-proBNP levels improve with treatment of chronic HF, with lowering of levels over time in general, correlating with improved clinical outcomes.(248,251,254,260) Thus, BNP or NT-proBNP “guided” therapy has been studied against standard care without natriuretic peptide measurement to determi”